DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $55,740,000 | +0.2% | 315,217 | -51.4% | 1.03% | -26.7% |
| Q3 2017 | $55,647,000 | +6.5% | 648,721 | +17.7% | 1.41% | +25.2% |
| Q1 2016 | $52,268,000 | +32.9% | 551,000 | +30.1% | 1.12% | +37.8% |
| Q4 2015 | $39,331,000 | -66.6% | 423,464 | -69.4% | 0.82% | -62.2% |
| Q3 2015 | $117,821,000 | -31.5% | 1,382,710 | -31.2% | 2.16% | -21.1% |
| Q2 2015 | $172,049,000 | +58.6% | 2,010,148 | +57.3% | 2.73% | +56.9% |
| Q1 2015 | $108,513,000 | -4.9% | 1,278,121 | -4.0% | 1.74% | -12.1% |
| Q4 2014 | $114,116,000 | +43.3% | 1,331,421 | +27.1% | 1.98% | +20.5% |
| Q3 2014 | $79,621,000 | +51.8% | 1,047,931 | +57.3% | 1.64% | +38.0% |
| Q2 2014 | $52,447,000 | -0.0% | 666,160 | -4.7% | 1.19% | -2.3% |
| Q1 2014 | $52,451,000 | -28.8% | 699,352 | -26.7% | 1.22% | -33.8% |
| Q4 2013 | $73,641,000 | -6.5% | 953,905 | -16.0% | 1.84% | -16.2% |
| Q3 2013 | $78,748,000 | +10.0% | 1,136,007 | +0.4% | 2.20% | +5.2% |
| Q2 2013 | $71,611,000 | – | 1,131,300 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |